{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:14:49Z","timestamp":1648822489189},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12094-012-0987-8","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T10:40:36Z","timestamp":1359369636000},"page":"643-651","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy"],"prefix":"10.1007","volume":"15","author":[{"given":"V.","family":"Macias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gonzalez Celador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marti-Macia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cigarral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Perez-Romasanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"issue":"5","key":"987_CR1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","volume":"43","author":"DJ Brenner","year":"1999","unstructured":"Brenner DJ, Hall EJ (1999) Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43(5):1095\u20131101","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"987_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","volume":"52","author":"DJ Brenner","year":"2002","unstructured":"Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52(1):6\u201313","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"987_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","volume":"55","author":"JZ Wang","year":"2003","unstructured":"Wang JZ, Guerrero M, Li XA (2003) How low is the alpha\/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55(1):194\u2013203","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"987_CR4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","volume":"56","author":"JF Fowler","year":"2003","unstructured":"Fowler JF, Ritter MA, Chappell RJ, Brenner DJ (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56(4):1093\u20131104","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"987_CR5","first-page":"521","volume":"169","author":"SM Deore","year":"1993","unstructured":"Deore SM, Shrivastava SK, Supe SJ, Viswanathan PS, Dinshaw KA (1993) Alpha\/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications. Strahlenther Onkol 169(9):521\u2013526","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"987_CR6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","volume":"60","author":"DJ Brenner","year":"2004","unstructured":"Brenner DJ (2004) Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60(4):1013\u20131015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"987_CR7","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1088\/0031-9155\/51\/16\/012","volume":"51","author":"M Guerrero","year":"2006","unstructured":"Guerrero M, Li XA (2006) Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy. Phys Med Biol 51(16):4063\u20134071","journal-title":"Phys Med Biol"},{"issue":"740","key":"987_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62(740):679\u2013694","journal-title":"Br J Radiol"},{"issue":"5","key":"987_CR9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(03)00752-1","volume":"57","author":"JE Livsey","year":"2003","unstructured":"Livsey JE, Cowan RA, Wylie JP, Swindell R, Read G, Khoo VS et al (2003) Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. Int J Radiat Oncol Biol Phys 57(5):1254\u20131259","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"987_CR10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0360-3016(02)04146-9","volume":"55","author":"EEK Yeoh","year":"2003","unstructured":"Yeoh EEK, Fraser RJ, McGowan RE, Botten RJ, Di Matteo AC, Roos DE et al (2003) Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial. Int J Radiat Oncol Biol Phys 55(4):943\u2013955","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"987_CR11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","volume":"68","author":"PA Kupelian","year":"2007","unstructured":"Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A (2007) Hypofractionated intensity-modulated radiotherapy (70\u00a0Gy at 2.5\u00a0Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68(5):1424\u20131430","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"987_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0090-4295(03)00144-4","volume":"62","author":"LV Rodr\u00edguez","year":"2003","unstructured":"Rodr\u00edguez LV, Blander DS, Dorey F, Raz S, Zimmern P (2003) Discrepancy in patient and physician perception of patient\u2019s quality of life related to urinary symptoms. Urology 62(1):49\u201353","journal-title":"Urology"},{"issue":"5","key":"987_CR13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"987_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","volume":"64","author":"A Pollack","year":"2006","unstructured":"Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B et al (2006) Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 64(2):518\u2013526","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"987_CR15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","volume":"69","author":"JM Martin","year":"2007","unstructured":"Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J et al (2007) Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 69(4):1084\u20131089","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"987_CR16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijrobp.2008.01.023","volume":"72","author":"F Leborgne","year":"2008","unstructured":"Leborgne F, Fowler J (2008) Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation. Int J Radiat Oncol Biol Phys 72(3):770\u2013776","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"987_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijrobp.2008.04.005","volume":"73","author":"S Arcangeli","year":"2009","unstructured":"Arcangeli S, Strigari L, Soete G, De Meerleer G, Gomellini S, Fonteyne V et al (2009) Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial. Int J Radiat Oncol Biol Phys 73(1):39\u201345","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"987_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.urolonc.2009.10.004","volume":"29","author":"BA Jereczek-Fossa","year":"2011","unstructured":"Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Cambria R, Garibaldi C et al (2011) Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation. Urol Oncol 29(5):523\u2013532","journal-title":"Urol Oncol"},{"issue":"5","key":"987_CR19","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2010.04.054","volume":"80","author":"M Lock","year":"2011","unstructured":"Lock M, Best L, Wong E, Bauman G, D\u2019Souza D, Venkatesan V et al (2011) A phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 80(5):1306\u20131315","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"987_CR20","first-page":"3555","volume":"31","author":"M Valeriani","year":"2011","unstructured":"Valeriani M, Monaco F, Osti MF, De Sanctis V, Minniti G, Enrici RM (2011) Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicity. Anticancer Res 31(10):3555\u20133558","journal-title":"Anticancer Res"},{"issue":"3","key":"987_CR21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0360-3016(03)00638-2","volume":"57","author":"T Craig","year":"2003","unstructured":"Craig T, Moiseenko V, Battista J, Van Dyk J (2003) The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 57(3):833\u2013842","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"987_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2005.08.037","volume":"64","author":"WY Song","year":"2006","unstructured":"Song WY, Schaly B, Bauman G, Battista JJ, Van Dyk J (2006) Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. Int J Radiat Oncol Biol Phys 64(1):289\u2013300","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"987_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ijrobp.2006.10.040","volume":"67","author":"V Vavassori","year":"2007","unstructured":"Vavassori V, Fiorino C, Rancati T, Magli A, Fellin G, Baccolini M et al (2007) Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 67(5):1401\u20131410","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"987_CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.radonc.2006.08.007","volume":"80","author":"M Stasi","year":"2006","unstructured":"Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P et al (2006) Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 80(3):363\u2013370","journal-title":"Radiother Oncol"},{"issue":"1","key":"987_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1120\/jacmp.v8i1.2286","volume":"8","author":"V Moiseenko","year":"2007","unstructured":"Moiseenko V, Liu M, Kristensen S, Gelowitz G, Berthelet E (2007) Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study. J Appl Clin Med Phys. 8(1):55\u201368","journal-title":"J Appl Clin Med Phys."},{"issue":"1","key":"987_CR26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00005392-199707000-00025","volume":"158","author":"OW Hakenberg","year":"1997","unstructured":"Hakenberg OW, Pinnock CB, Marshall VR (1997) Does evaluation with the international prostate symptom score predict the outcome of transurethral resection of the prostate? J Urol 158(1):94\u201399","journal-title":"J Urol"},{"issue":"4","key":"987_CR27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","volume":"61","author":"STH Peeters","year":"2005","unstructured":"Peeters STH, Heemsbergen WD, van Putten WLJ, Slot A, Tabak H, Mens JW et al (2005) Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68\u00a0Gy to 78\u00a0Gy. Int J Radiat Oncol Biol Phys 61(4):1019\u20131034","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"987_CR28","first-page":"15","volume":"70","author":"F Russo","year":"1998","unstructured":"Russo F, Di Pasquale B, Romano G, Vicentini C, Manieri C, Tubaro A et al (1998) International prostate symptom score: comparison of doctor and patient. Arch Ital Urol Androl 70(3 Suppl):15\u201324","journal-title":"Arch Ital Urol Androl"},{"issue":"1","key":"987_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-8140(99)00027-4","volume":"51","author":"JW Denham","year":"1999","unstructured":"Denham JW, O\u2019Brien PC, Dunstan RH, Johansen J, See A, Hamilton CS et al (1999) Is there more than one late radiation proctitis syndrome? Radiother Oncol 51(1):43\u201353","journal-title":"Radiother Oncol"},{"issue":"1","key":"987_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(97)00234-4","volume":"38","author":"AL Hanlon","year":"1997","unstructured":"Hanlon AL, Schultheiss TE, Hunt MA, Movsas B, Peter RS, Hanks GE (1997) Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 38(1):59\u201363","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0987-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0987-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0987-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:51:34Z","timestamp":1559447494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0987-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0987-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}